The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
|
---|---|
Published in |
Frontiers in oncology, April 2020
|
DOI | 10.3389/fonc.2020.00414 |
Pubmed ID | |
Authors |
Alberto Bongiovanni, Chiara Liverani, Federica Recine, Valentina Fausti, Laura Mercatali, Alessandro Vagheggini, Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Giandomenico Di Menna, Alessandro De Vita, Stefano Severi, Silvia Nicolini, Toni Ibrahim |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 50% |
Switzerland | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 17% |
Student > Ph. D. Student | 3 | 17% |
Student > Doctoral Student | 1 | 6% |
Professor | 1 | 6% |
Researcher | 1 | 6% |
Other | 1 | 6% |
Unknown | 8 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 33% |
Agricultural and Biological Sciences | 1 | 6% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Computer Science | 1 | 6% |
Engineering | 1 | 6% |
Other | 0 | 0% |
Unknown | 8 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2020.
All research outputs
#21,381,047
of 26,245,314 outputs
Outputs from Frontiers in oncology
#11,785
of 22,949 outputs
Outputs of similar age
#310,648
of 403,406 outputs
Outputs of similar age from Frontiers in oncology
#242
of 484 outputs
Altmetric has tracked 26,245,314 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,949 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 403,406 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 484 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.